Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsDividends payablesGoodwillGoodwill & IntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Selectis Health (GBCS) Preferred Shares (2017 - 2025)

Selectis Health's Preferred Shares history spans 13 years, with the latest figure at $401000.0 for Q3 2025.

  • For Q3 2025, Preferred Shares rose 6.93% year-over-year to $401000.0; the TTM value through Sep 2025 reached $401000.0, up 6.93%, while the annual FY2024 figure was $375000.0, 0.0% changed from the prior year.
  • Preferred Shares for Q3 2025 was $401000.0 at Selectis Health, up from $375000.0 in the prior quarter.
  • Across five years, Preferred Shares topped out at $401000.0 in Q3 2021 and bottomed at $375000.0 in Q1 2021.
  • The 5-year median for Preferred Shares is $375000.0 (2021), against an average of $387315.8.
  • The largest annual shift saw Preferred Shares fell 6.48% in 2021 before it rose 6.93% in 2022.
  • A 5-year view of Preferred Shares shows it stood at $401000.0 in 2021, then changed by 0.0% to $401000.0 in 2022, then dropped by 6.48% to $375000.0 in 2023, then changed by 0.0% to $375000.0 in 2024, then grew by 6.93% to $401000.0 in 2025.
  • Per Business Quant, the three most recent readings for GBCS's Preferred Shares are $401000.0 (Q3 2025), $375000.0 (Q2 2025), and $401000.0 (Q1 2025).